long-term effects of glp-1 receptor agonists Glucagon-Like Peptide-1 Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review the Key Evidence with Practical Considerations | Diabetes Therapy GLP-1 Side Effects and Semaglutide:

Inzucchi SE, Zinman B, Fitchett D, Wanner C, Ferrannini E, Schumacher M, et al

Ammar RA, Mohamed AF, Kamal MM, Safar MM, Abdelkader NF

Trained muscles feel rounder and more vascular during and immediately after training

(They studied participants who did not have diabetes because the disease introduces more confounding variables.) The researchers suspected that people with the PAM variant would have lower levels of GLP-1 in their blood, perhaps because the unamidated form would be less stable

F., Larijani, B., Heshmat, R., Fakhrzadeh, H., Radjabipour, B., Toliat, T., & Raza, M

Genetic recombinant experiments were reviewed by Safety Officer in RIKEN, and approved by the director of RIKEN Wako Campus (approval number: 2022-029(1))